IFNA1 and systemic lupus erythematosus: Together this in vitro modelling of SLE B-cell CSR indicates that high concentrations of circulating IFNα in SLE patients may contribute to the impaired CSR of B cells and subsequently result in weaker antibody responses following SARS-CoV-2 vaccination.